Opthea (OPT) Appoints Quinton Oswald and Susan Orr to its Board

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 10/5/2026

1. NVDA
2. PCVX
3. SPY
4. ATH
5. PTC
6. CME
7. USO
8. AMD
9. EVTL
10. KLC

Go back to Opthea (OPT) Appoints Quinton Oswald and Susan Orr to its Board

Opthea strengthens its Board of Directors

April 22, 2022 8:15 AM EDT

MELBOURNE, Australia, April 22, 2022 (GLOBE NEWSWIRE) -- Opthea Limited (ASX:OPT; Nasdaq: OPT), a clinical stage biopharmaceutical company developing novel therapies to treat highly prevalent and progressive retinal diseases, today announced the appointment of Mr. Quinton Oswald and Dr. Susan Orr to its Board of Directors, effective immediately following election at a General Meeting of Shareholders on April 21st, 2022.

Mr. Oswald and Dr. Orr have deep experience leading biotech companies and launching commercial products for the treatment of wet age-related macular degeneration (wet AMD) and other ophthalmic diseases.

... More